Merrion is pleased to announce that all resolutions proposed at the AGM and EGM held earlier today were approved.
As less than 90% in nominal value of the ordinary shares of the Company and entitled to vote at general meetings of the Company voted in favour of the first four resolutions proposed at the EGM, the Company cannot commence the members' voluntary winding up until the expiry of 30 days after the date of the EGM. Once this thirty day period has elapsed it is envisaged that the liquidation process will proceed.
Pursuant to the approval of the resolution to cancel the listing, trading of the Ordinary Shares of Merrion on ESM will be cancelled on 21 September 2016.
Merrion Pharmaceuticals plc.
Davy Corporate Finance
Anthony Farrell / Barry Murphy
T +353 1 679 6363